147 related articles for article (PubMed ID: 7811548)
21. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.
Miles SA; Rezai AR; Salazar-González JF; Vander Meyden M; Stevens RH; Logan DM; Mitsuyasu RT; Taga T; Hirano T; Kishimoto T
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4068-72. PubMed ID: 1693429
[TBL] [Abstract][Full Text] [Related]
22. Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells.
Klouche M; Brockmeyer N; Knabbe C; Rose-John S
AIDS; 2002 May; 16(8):F9-18. PubMed ID: 12004288
[TBL] [Abstract][Full Text] [Related]
23. Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein.
Husain SR; Obiri NI; Gill P; Zheng T; Pastan I; Debinski W; Puri RK
Clin Cancer Res; 1997 Feb; 3(2):151-6. PubMed ID: 9815666
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
25. Induction of IL-6 gene expression in Kaposi's sarcoma cells.
Yang J; Hagan MK; Offermann MK
J Immunol; 1994 Jan; 152(2):943-55. PubMed ID: 8283061
[TBL] [Abstract][Full Text] [Related]
26. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.
Miles SA; Martínez-Maza O; Rezai A; Magpantay L; Kishimoto T; Nakamura S; Radka SF; Linsley PS
Science; 1992 Mar; 255(5050):1432-4. PubMed ID: 1542793
[TBL] [Abstract][Full Text] [Related]
27. Structure/function analysis of the transmembrane domain of DAB389-interleukin-2, an interleukin-2 receptor-targeted fusion toxin. The amphipathic helical region of the transmembrane domain is essential for the efficient delivery of the catalytic domain to the cytosol of target cells.
vanderSpek JC; Mindell JA; Finkelstein A; Murphy JR
J Biol Chem; 1993 Jun; 268(16):12077-82. PubMed ID: 8505330
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft.
Husain SR; Puri RK
Blood; 2000 Jun; 95(11):3506-13. PubMed ID: 10828036
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 infection and modulation of cytokine and growth factor expression in Kaposi's sarcoma-derived cells in vitro.
Huang YQ; Li JJ; Kim KS; Nicolaides A; Zhang WG; Le J; Poiesz BJ; Friedman-Kien AE
AIDS; 1993 Mar; 7(3):317-22. PubMed ID: 8471192
[TBL] [Abstract][Full Text] [Related]
30. p38MAP kinase is a negative regulator for ERK1/2-mediated growth of AIDS-associated Kaposi's sarcoma cells.
Murakami-Mori K; Mori S; Nakamura S
Biochem Biophys Res Commun; 1999 Nov; 264(3):676-82. PubMed ID: 10543991
[TBL] [Abstract][Full Text] [Related]
31. Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis.
Mallery SR; Bailer RT; Hohl CM; Ng-Bautista CL; Ness GM; Livingston BE; Hout BL; Stephens RE; Brierley GP
J Cell Biochem; 1995 Nov; 59(3):317-28. PubMed ID: 8567750
[TBL] [Abstract][Full Text] [Related]
32. Site-directed and deletion mutational analysis of the receptor binding domain of the interleukin-6 receptor targeted fusion toxin DAB389-IL-6.
Jean LF; Waters CA; Keemy D; Murphy JR
Protein Eng; 1993 Apr; 6(3):305-11. PubMed ID: 8506265
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma.
Masood R; Cai J; Tulpule A; Zheng T; Hamilton A; Sharma S; Espina BM; Smith DL; Gill PS
Clin Cancer Res; 2001 Sep; 7(9):2693-702. PubMed ID: 11555581
[TBL] [Abstract][Full Text] [Related]
34. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes.
Gabay C; Silacci P; Genin B; Mentha G; Le Coultre C; Guerne PA
Eur J Immunol; 1995 Aug; 25(8):2378-83. PubMed ID: 7545121
[TBL] [Abstract][Full Text] [Related]
35. Production, characterization and cytotoxic properties of a diphtheria toxin-ciliary neurotrophic factor fusion protein.
Negro A; Skaper SD
Protein Eng; 1995 Feb; 8(2):175-83. PubMed ID: 7630888
[TBL] [Abstract][Full Text] [Related]
36. Low molecular weight components but not dimeric HCG inhibit growth and down-regulate AP-1 transcription factor in Kaposi's sarcoma cells.
Kachra Z; Guo WX; Sairam MR; Antakly T
Endocrinology; 1997 Sep; 138(9):4038-41. PubMed ID: 9275098
[TBL] [Abstract][Full Text] [Related]
37. AIDS-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin.
Weich HA; Salahuddin SZ; Gill P; Nakamura S; Gallo RC; Folkmann J
Am J Pathol; 1991 Dec; 139(6):1251-8. PubMed ID: 1750501
[TBL] [Abstract][Full Text] [Related]
38. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients.
Uccini S; Sirianni MC; Vincenzi L; Topino S; Stoppacciaro A; Lesnoni La Parola I; Capuano M; Masini C; Cerimele D; Cella M; Lanzavecchia A; Allavena P; Mantovani A; Baroni CD; Ruco LP
Am J Pathol; 1997 Mar; 150(3):929-38. PubMed ID: 9060831
[TBL] [Abstract][Full Text] [Related]
39. Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors.
Barillari G; Franzese O; Comandini A; Bonmassar E; Ensoli B
Oncol Rep; 2010 Jul; 24(1):219-23. PubMed ID: 20514465
[TBL] [Abstract][Full Text] [Related]
40. Characterization and receptor specific toxicity of two diphtheria toxin-related interleukin-3 fusion proteins DAB389-mIL-3 and DAB389-(Gly4Ser)2-mIL-3.
Liger D; vanderSpek JC; Gaillard C; Cansier C; Murphy JR; Leboulch P; Gillet D
FEBS Lett; 1997 Apr; 406(1-2):157-61. PubMed ID: 9109408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
